1
Goetgebuer, R L, Kreijne, J E, Aitken, C A, Dijkstra, G, Hoentjen, F, de Boer, N K, Oldenburg, B, van der Meulen, A E, Ponsioen, C I J, Pierik, M J, van Kemenade, F J, de Kok, I M C M, Siebers, A G, Manniën, J, van der Woude, C J, de Vries, A C
Veröffentlicht in: Goetgebuer , R L , Kreijne , J E , Aitken , C A , Dijkstra , G , Hoentjen , F , de Boer , N K , Oldenburg , B , van der Meulen , A E , Ponsioen , C I J , Pierik , M J , van Kemenade , F J , de Kok , I M C M , Siebers , A G , Manniën , J , van der Woude , C J & de Vries , A C 2021 , ' Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease : A Case-controlled Cohort Study ' , Journal of Crohn's & Colitis , vol. 15 , no. 9 , pp. 1464-1473 . https://doi.org/10.1093/ecco-jcc/jjab036;
2021
Veröffentlicht in: Goetgebuer , R L , Kreijne , J E , Aitken , C A , Dijkstra , G , Hoentjen , F , de Boer , N K , Oldenburg , B , van der Meulen , A E , Ponsioen , C I J , Pierik , M J , van Kemenade , F J , de Kok , I M C M , Siebers , A G , Manniën , J , van der Woude , C J & de Vries , A C 2021 , ' Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease : A Case-controlled Cohort Study ' , Journal of Crohn's & Colitis , vol. 15 , no. 9 , pp. 1464-1473 . https://doi.org/10.1093/ecco-jcc/jjab036;
2021
2
Biemans, V.B.C., Sleutjes, J.A.M., de Vries, A.C., Bodelier, A.G.L., Dijkstra, G., Oldenburg, B., Lowenberg, M., van Bodegraven, A.A., van der Meulen-de Jong, A.E., de Boer, N.K.H., Srivastava, N., West, R.L., Romkens, T.E.H., Horje, C.H.T.S., Jansen, J.M., van der Woude, C.J., Hoekstra, J., Weersma, R.K., van Schaik, F.D.M., Hoentjen, F., Pierik, M.J.
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , V B C , Sleutjes , J A M , de Vries , A C , Bodelier , A G L , Dijkstra , G , Oldenburg , B , Lowenberg , M , van Bodegraven , A A , van der Meulen-de Jong , A E , de Boer , N K H , Srivastava , N , West , R L , Romkens , T E H , Horje , C H T S , Jansen , J M , van der Woude , C J , Hoekstra , J , Weersma , R K , van Schaik , F D M , Hoentjen , F , Pierik , M J & Dutch Initiative Crohn and Colitis 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology & Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020